(Q33376138)

26 July 2017

1 reference

title

Treatment and prevention of enterohemorrhagic Escherichia coli infection and hemolytic uremic syndrome (English)

1 reference

enterohaemorrhagic Escherichia coli infection

26 July 2017

main subject

1 reference

1 reference

Paul N Goldwater

1 reference

26 July 2017

publication date

1 August 2007

1 reference

Expert Review of Anti-infective Therapy

26 July 2017

published in

1 reference

26 July 2017

1 reference

26 July 2017

1 reference

26 July 2017

page(s)

653-663

1 reference

Cytotoxic Escherichia coli serotypes

26 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.653

Sporadic cases of haemolytic-uraemic syndrome associated with faecal cytotoxin and cytotoxin-producing Escherichia coli in stools

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.653

An outbreak of Escherichia coli O157 infection following exposure to a contaminated building

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.653

Escherichia coli 'O' group serology of a haemolytic uraemic syndrome (HUS) epidemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.653

New perspectives on the role of Escherichia coli O157:H7 and other enterohaemorrhagic E. coli serotypes in human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.653

Pathogenesis of thrombotic thrombocytopenic purpura: ADAMTS13 deficiency and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.653

Comparison of a Shiga Toxin Enzyme-Linked Immunosorbent Assay and Two Types of PCR for Detection of Shiga Toxin-Producing Escherichia coli in Human Stool Specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.653

Infections with Escherichia coli O157:H7 in Washington State. The first year of statewide disease surveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.653

The management of VTEC O157 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.653

Haemolytic anaemia after childhood Escherichia coli O 157 .H7 infection: are females at increased risk?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.653

Inflammatory and immunological parameters in children with haemolytic uremic syndrome (HUS) and gastroenteritis-pathophysiological and diagnostic clues

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.653

Complement factor H mutations and gene polymorphisms in haemolytic uraemic syndrome: the C-257T, the A2089G and the G2881T polymorphisms are strongly associated with the disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.653

Diversity of virulence patterns among shiga toxin-producing Escherichia coli from human clinical cases-need for more detailed diagnostics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.653

First-time isolation and characterization of a bacteriophage encoding the Shiga toxin 2c variant, which is globally spread in strains of Escherichia coli O157.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.653

Mutation of toxB and a truncated version of the efa-1 gene in Escherichia coli O157:H7 influences the expression and secretion of locus of enterocyte effacement-encoded proteins but not intestinal colonization in calves or sheep.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.653

Description of a 111-kb pathogenicity island (PAI) encoding various virulence features in the enterohemorrhagic E. coli (EHEC) strain RW1374 (O103:H2) and detection of a similar PAI in other EHEC strains of serotype 0103:H2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.653

Interaction of Shiga toxin from Escherichia coli with human intestinal epithelial cell lines and explants: Stx2 induces epithelial damage in organ culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.653

Characterization of the baboon responses to Shiga-like toxin: descriptive study of a new primate model of toxic responses to Stx-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.653

Shiga toxin of enterohemorrhagic Escherichia coli type O157:H7 promotes intestinal colonization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.653

Evidence that glutamic acid 167 is an active-site residue of Shiga-like toxin I

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.653

4-Aminopyrazolo[3,4-d]pyrimidine (4-APP) as a novel inhibitor of the RNA and DNA depurination induced by Shiga toxin 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.653

Prothrombotic coagulation abnormalities preceding the hemolytic-uremic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.653

Escherichia coli 'O' group serological responses and clinical correlations in epidemic HUS patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.653

Involvement of the fractalkine pathway in the pathogenesis of childhood hemolytic uremic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.653

Shiga toxins induce, superinduce, and stabilize a variety of C-X-C chemokine mRNAs in intestinal epithelial cells, resulting in increased chemokine expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.653

Shiga toxin-2 induces neutrophilia and neutrophil activation in a murine model of hemolytic uremic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.653

The Shiga toxin 2 B subunit inhibits net fluid absorption in human colon and elicits fluid accumulation in rat colon loops.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.653

Bovine immune response to shiga-toxigenic Escherichia coli O157:H7

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.653

Application of bacteriophages to control intestinal Escherichia coli O157:H7 levels in ruminants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.653

Fecal prevalence of Escherichia coli O157, Salmonella, Listeria, and Bacteriophage Infecting E. coli O157:H7 in feedlot cattle in the Southern Plains region of the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.653

Isolation and characterization of a new T-even bacteriophage, CEV1, and determination of its potential to reduce Escherichia coli O157:H7 levels in sheep

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.653

Seasonal shedding of Escherichia coli O157:H7 in ruminants: a new hypothesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.653

Relative nephroprotection during Escherichia coli O157:H7 infections: association with intravenous volume expansion

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.653

The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.653

Risk of hemolytic uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 enteritis: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.653

Strain-specific differences in the amount of Shiga toxin released from enterohemorrhagic Escherichia coli O157 following exposure to subinhibitory concentrations of antimicrobial agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.653

Quinolone antibiotics induce Shiga toxin-encoding bacteriophages, toxin production, and death in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.653

Efficacy of antibiotic therapy for infection with Shiga-like toxin-producing Escherichia coli O157:H7 in mice with protein-calorie malnutrition

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.653

Low risk of hemolytic uremic syndrome after early effective antimicrobial therapy for Shigella dysenteriae type 1 infection in Bangladesh

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.653

Escherichia coli O157:H7 infections: discordance between filterable fecal shiga toxin and disease outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.653

Polyisobutylmethacrylate modifies glycolipid binding specificity of verotoxin 1 in thin-layer chromatogram overlay procedures

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.653

Effect of an oral Shiga toxin-binding agent on diarrhea-associated hemolytic uremic syndrome in children: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.653

Neutralization of Shiga toxins Stx1, Stx2c, and Stx2e by recombinant bacteria expressing mimics of globotriose and globotetraose

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.653

Refinement of a therapeutic Shiga toxin-binding probiotic for human trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.653

Structural analysis of the interaction between Shiga toxin B subunits and linear polymers bearing clustered globotriose residues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.653

Oral therapeutic agents with highly clustered globotriose for treatment of Shiga toxigenic Escherichia coli infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.653

The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli. 1985.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.653

Anticytotoxin-neutralizing antibodies in immune globulin preparations: potential use in hemolytic-uremic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.653

Passive immunisation of children with bovine colostrum containing antibodies to human rotavirus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.653

Bovine colostrum ameliorates diarrhea in infection with diarrheagenic Escherichia coli, shiga toxin-producing E. Coli, and E. coli expressing intimin and hemolysin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.653

Antibodies to lipopolysaccharide block adherence of Shiga toxin-producingEscherichia colito human intestinal epithelial (Henle 407) cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.653

Analysis and genetic manipulation of Shigella virulence determinants for vaccine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.653

Immunization of mice with live oral vaccine based on a Salmonella enterica (sv Typhimurium) aroA strain expressing the Escherichia coli O111 O antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.653

Genetically modified Shiga toxin 2e (Stx2e) producing Escherichia coli is a vaccine candidate for porcine edema disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.653

Protection against hemorrhagic colitis in an animal model by oral immunization with isogeneic rabbit enteropathogenic Escherichia coli attenuated by truncating intimin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.653

Delivery of heterologous protein antigens via hemolysin or autotransporter systems by an attenuated ler mutant of rabbit enteropathogenic Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.653

Production of secretory immunoglobulin A against Shiga toxin-binding subunits in mice by mucosal immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.653

Genetic medicine at the RNA level: modifications of the genetic repertoire for therapeutic purposes by pre-mRNA trans-splicing

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.653

Development of a hybrid Shiga holotoxoid vaccine to elicit heterologous protection against Shiga toxins types 1 and 2☆

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.653

21 January 2018

Identifiers

DOI

10.1586/14787210.5.4.653

1 reference

26 July 2017

1 reference